Enfusion Stock Analysis

ENFN Stock  USD 9.38  0.08  0.86%   
Enfusion is fairly valued with Real Value of 9.63 and Target Price of 10.17. The main objective of Enfusion stock analysis is to determine its intrinsic value, which is an estimate of what Enfusion is worth, separate from its market price. There are two main types of Enfusion's stock analysis: fundamental analysis and technical analysis.
The Enfusion stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Enfusion is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Enfusion Stock trading window is adjusted to America/New York timezone.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.

Enfusion Stock Analysis Notes

About 96.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.35. Enfusion had not issued any dividends in recent years. Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois. Enfusion Inc operates under SoftwareApplication classification in the United States and is traded on New York Stock Exchange. It employs 892 people. To learn more about Enfusion call the company at 312 253 9800 or check out https://www.enfusion.com.

Enfusion Quarterly Total Revenue

51.17 Million

Enfusion Investment Alerts

Enfusion is unlikely to experience financial distress in the next 2 years
Enfusion has a very strong financial position based on the latest SEC filings
Over 96.0% of the company shares are held by institutions such as insurance companies
Latest headline from thelincolnianonline.com: Enfusion Announces Positive Financial Results for Q3 2024

Enfusion Upcoming and Recent Events

Earnings reports are used by Enfusion to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
5th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
5th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Enfusion Largest EPS Surprises

Earnings surprises can significantly impact Enfusion's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-05
2024-09-300.060.05-0.0116 
2024-08-06
2024-06-300.060.05-0.0116 
2024-03-12
2023-12-310.050.04-0.0120 
View All Earnings Estimates

Enfusion Environmental, Social, and Governance (ESG) Scores

Enfusion's ESG score is a quantitative measure that evaluates Enfusion's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Enfusion's operations that may have significant financial implications and affect Enfusion's stock price as well as guide investors towards more socially responsible investments.

Enfusion Stock Institutional Investors

Shares
T. Rowe Price Investment Management,inc.2024-06-30
1.4 M
Next Century Growth Investors Llc2024-06-30
1.1 M
Geode Capital Management, Llc2024-06-30
959 K
State Street Corp2024-06-30
931.2 K
Wellington Management Company Llp2024-06-30
915.3 K
Scalar Gauge Management, Llc2024-06-30
613.5 K
Morgan Stanley - Brokerage Accounts2024-06-30
580.6 K
Bank Of America Corp2024-06-30
579.7 K
Impax Asset Management Group Plc2024-06-30
540 K
Iconiq Capital, Llc2024-06-30
14 M
Brown Capital Management, Llc2024-06-30
8.6 M
Note, although Enfusion's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Enfusion Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 877.66 M.

Enfusion Profitablity

The company has Profit Margin (PM) of 0.02 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.06  0.06 
Return On Capital Employed 0.13  0.14 
Return On Assets 0.06  0.06 
Return On Equity 0.11  0.12 

Management Efficiency

Enfusion has return on total asset (ROA) of 0.0592 % which means that it generated a profit of $0.0592 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0548 %, meaning that it created $0.0548 on every $100 dollars invested by stockholders. Enfusion's management efficiency ratios could be used to measure how well Enfusion manages its routine affairs as well as how well it operates its assets and liabilities. As of the 9th of November 2024, Return On Tangible Assets is likely to grow to 0.06. Also, Return On Capital Employed is likely to grow to 0.14. At this time, Enfusion's Net Tangible Assets are very stable compared to the past year. As of the 9th of November 2024, Return On Tangible Assets is likely to grow to 0.06, while Total Assets are likely to drop about 88.2 M.
Last ReportedProjected for Next Year
Book Value Per Share 0.88  0.92 
Tangible Book Value Per Share 0.88  0.92 
Enterprise Value Over EBITDA 40.68  71.39 
Price Book Value Ratio 15.94  16.74 
Enterprise Value Multiple 40.68  71.39 
Price Fair Value 15.94  16.74 
Enterprise Value960.7 M1.9 B
The strategic decisions made by Enfusion management significantly impact its financial stability and market performance. Evaluating these factors helps determine whether the stock is a worthwhile investment.
Operating Margin
0.0583
Profit Margin
0.017
Beta
0.934
Return On Assets
0.0592
Return On Equity
0.0548

Technical Drivers

As of the 9th of November, Enfusion shows the Downside Deviation of 1.7, mean deviation of 1.49, and Coefficient Of Variation of 694.19. Enfusion technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Enfusion Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Enfusion middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Enfusion. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Enfusion Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Enfusion insiders, such as employees or executives, is commonly permitted as long as it does not rely on Enfusion's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Enfusion insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Enfusion Outstanding Bonds

Enfusion issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Enfusion uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Enfusion bonds can be classified according to their maturity, which is the date when Enfusion has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Enfusion Predictive Daily Indicators

Enfusion intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Enfusion stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Enfusion Corporate Filings

8K
4th of November 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
29th of October 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
25th of October 2024
An amended filing to the original Schedule 13G
ViewVerify
F4
24th of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
12th of September 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
6th of September 2024
An amended filing to the original Schedule 13G
ViewVerify
8K
6th of August 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
25th of July 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Enfusion Forecast Models

Enfusion's time-series forecasting models are one of many Enfusion's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Enfusion's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Enfusion Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Enfusion prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Enfusion shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Enfusion. By using and applying Enfusion Stock analysis, traders can create a robust methodology for identifying Enfusion entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.07  0.07 
Operating Profit Margin 0.07  0.07 
Net Profit Margin 0.03  0.04 
Gross Profit Margin 0.67  0.77 

Current Enfusion Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Enfusion analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Enfusion analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
10.17Buy9Odds
Enfusion current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Enfusion analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Enfusion stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Enfusion, talking to its executives and customers, or listening to Enfusion conference calls.
Enfusion Analyst Advice Details

Enfusion Stock Analysis Indicators

Enfusion stock analysis indicators help investors evaluate how Enfusion stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Enfusion shares will generate the highest return on investment. By understating and applying Enfusion stock analysis, traders can identify Enfusion position entry and exit signals to maximize returns.
Begin Period Cash Flow62.5 M
Common Stock Shares Outstanding129.4 M
Total Stockholder Equity53.7 M
Tax Provision1.4 M
Quarterly Earnings Growth Y O Y-0.271
Property Plant And Equipment Net32.6 M
Cash And Short Term Investments35.6 M
Cash35.6 M
Accounts Payable2.2 M
Net Debt-20.2 M
50 Day M A8.792
Total Current Liabilities20.3 M
Other Operating Expenses162.6 M
Non Current Assets Total39.1 M
Forward Price Earnings41.1523
Non Currrent Assets Other6.5 M
Stock Based Compensation7.5 M
When determining whether Enfusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enfusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enfusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enfusion Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enfusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
To learn how to invest in Enfusion Stock, please use our How to Invest in Enfusion guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enfusion. If investors know Enfusion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enfusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.27)
Earnings Share
0.04
Revenue Per Share
2.155
Quarterly Revenue Growth
0.154
Return On Assets
0.0592
The market value of Enfusion is measured differently than its book value, which is the value of Enfusion that is recorded on the company's balance sheet. Investors also form their own opinion of Enfusion's value that differs from its market value or its book value, called intrinsic value, which is Enfusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enfusion's market value can be influenced by many factors that don't directly affect Enfusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enfusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Enfusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enfusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.